Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation.

Saved in:
Bibliographic Details
Title: Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation.
Authors: Lin C; School of Pharmacy, National Taiwan University, Taipei, ROC., Hsu JL; School of Pharmacy, National Taiwan University, Taipei, ROC.; Department of Nursing, Chang Gung University of Science and Technology, Taoyuan City, ROC.; Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City, ROC., Hsu YT; School of Pharmacy, National Taiwan University, Taipei, ROC., Fan KC; School of Pharmacy, National Taiwan University, Taipei, ROC., Wu SS; School of Pharmacy, National Taiwan University, Taipei, ROC., Lin MH; Department and Graduate Institute of Medical Microbiology, College of Medicine, National Taiwan University, Taipei, ROC., Guh JH; School of Pharmacy, National Taiwan University, Taipei, ROC., Yu CW; School of Pharmacy, National Taiwan University, Taipei, ROC.
Source: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2025 Dec; Vol. 40 (1), pp. 2468355. Date of Electronic Publication: 2025 Feb 27.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1475-6374 (Electronic) Linking ISSN: 14756366 NLM ISO Abbreviation: J Enzyme Inhib Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1475-6374
DOI:10.1080/14756366.2025.2468355